Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors
- 1 February 2011
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 21 (4) , 515-524
Abstract
Aberrant DNA methylation (DNAm) was first linked to cancer over 25 yr ago. Since then, many studies have associated hypermethylation of tumor suppressor genes and hypomethylation of oncogenes to the tumorigenic process. However, most of these studies have been limited to the analysis of promoters and CpG islands (CGIs). Recently, new technologies for whole-genome DNAm (methylome) analysis have been developed, enabling unbiased analysis of cancer methylomes. By using MeDIP-seq, we report a sequencing-based comparative methylome analysis of malignant peripheral nerve sheath tumors (MPNSTs), benign neurofibromas, and normal Schwann cells. Analysis of these methylomes revealed a complex landscape of DNAm alterations. In contrast to what has been reported for other tumor types, no significant global hypomethylation was observed in MPNSTs using methylome analysis by MeDIP-seq. However, a highly significant (P < 10−100) directional difference in DNAm was found in satellite repeats, suggesting these repeats to be the main target for hypomethylation in MPNSTs. Comparative analysis of the MPNST and Schwann cell methylomes identified 101,466 cancer-associated differentially methylated regions (cDMRs). Analysis showed these cDMRs to be significantly enriched for two satellite repeat types (SATR1 and ARLα) and suggests an association between aberrant DNAm of these sequences and transition from healthy cells to malignant disease. Significant enrichment of hypermethylated cDMRs in CGI shores (P < 10−60), non–CGI-associated promoters (P < 10−4) and hypomethylated cDMRs in SINE repeats (P < 10−100) was also identified. Integration of DNAm and gene expression data showed that the expression pattern of genes associated with CGI shore cDMRs was able to discriminate between disease phenotypes. This study establishes MeDIP-seq as an effective method to analyze cancer methylomes.Keywords
This publication has 60 references indexed in Scilit:
- An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism ArraysCancer Research, 2004
- Malignant Peripheral Nerve Sheath TumorAmerican Journal of Surgical Pathology, 2003
- Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.Oncology Reports, 2003
- Methylation Target Array for Rapid Analysis of CpG Island Hypermethylation in Multiple Tissue GenomesThe American Journal of Pathology, 2003
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- DNA methylation in cancer: too much, but also too littleOncogene, 2002
- Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerHuman Molecular Genetics, 2002
- Malignant peripheral nerve sheath tumours in neurofibromatosis 1Journal of Medical Genetics, 2002
- Expression of mRNA for DNA methyltransferases and methyl-CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesisHepatology, 2001
- Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromasEuropean Journal of Human Genetics, 2000